Thus, even though within the same cell, NF-kB activity cannot be at the same time silenced and activated, the activity of NF-kB can change during the leukemogenesis of CLL and the role of the tumor suppressor mechanism in 13q14 could be required only at specific timepoints. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.